Pacira BioSciences Inc
(NAS:PCRX)
$
16.81
-0.7 (-4%)
Market Cap: 776.17 Mil
Enterprise Value: 998.18 Mil
PE Ratio: 0
PB Ratio: 1.03
GF Score: 72/100 Pacira Biosciences Inc at Barclays Global Healthcare Conference Transcript
Mar 12, 2020 / 01:00PM GMT
Release Date Price:
$33.11
(-5.91%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Good morning, everyone. Thank you for dialing in. My name is Balaji Prasad. I cover specialty pharma for Barclays. Continuing our health care conference virtually for day 3, we have with us today, Pacira Pharmaceuticals to -- for the 9 a.m. session. And from the management team side, we have with us Dave Stack, Chairman and CEO of Pacira; Ron Ellis, Senior Vice President, Corporate Strategy and Business Development; and Susan Mesco, Head of Investor Relations. Dave, Ron and Susan, good morning, and thank you for joining us.
David M. Stack
Pacira BioSciences, Inc. - Chairman & CEO
Good morning, Balaji. And Charlie Reinhart, our CFO, is also with us here.
Charles A. Reinhart
Pacira BioSciences, Inc. - CFO
Good morning.
Questions & Answers
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
So maybe a good point to start, Dave and Charlie, is the resounding guidance you gave
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot